Inhibition of mammary tumor growth by estrogens: Is there a specific role for estrogen receptors alpha and beta?

Breast Cancer Research and Treatment

Volumn 123, Issue 3, 2010, Pages 709-724

  Soldati, Rocío ^a   Wargon, Victoria ^a   Cerliani, Juan Pablo ^a   Giulianelli, Sebastián ^a   Vanzulli, Silvia Inés ^b   Gorostiaga, María Alicia ^a   Bolado, Julieta ^a   Do Campo, Pablo ^a   Molinolo, Alfredo ^c   Vollmer, Günter ^d   Lanari, Claudia ^a  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^b ACADEMIA NACIONAL DE MEDICINA   (Argentina)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Aif; Apoptosis; Bax; Bcl xl; Breast cancer; Caspase 9; DPN; Estrogen receptors alpha; Estrogen receptors beta; Mammary carcinomas; PPT; Progesterone receptors; Tumor regression

Indexed keywords

(4 HYDROXYPHENYL)PROPIONITRILE; 1,3,5 TRIS(4 HYDROXYPHENYL) 4 PROPYLPYRAZOLE; ALPHA6 INTEGRIN; ANTINEOPLASTIC AGENT; APOPTOSIS INDUCING FACTOR; CASPASE 9; CYCLIN D1; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; LAMININ; PROGESTERONE RECEPTOR; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; UNCLASSIFIED DRUG; 1,3,5-TRIS(4-HYDROXYPHENYL)-4-PROPYL-1H-PYRAZOLE; 2,3 BIS(4 HYDROXYPHENYL) PROPIONITRILE; 2,3-BIS(4-HYDROXYPHENYL)-PROPIONITRILE; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; BAX PROTEIN, MOUSE; BCL2L1 PROTEIN, MOUSE; CASP9 PROTEIN, MOUSE; CCND1 PROTEIN, MOUSE; NITRILE; PDCD8 PROTEIN, MOUSE; PHENOL DERIVATIVE; PROTEIN BCL X; PYRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER INHIBITION; CANCER MODEL; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CYTOSTASIS; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVATION; ESTROGEN ACTIVITY; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MITOCHONDRION; MITOSIS INDEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TUMOR DIFFERENTIATION; TUMOR REGRESSION; TUMOR VOLUME; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; BREAST TUMOR; DOSE RESPONSE; DRUG POTENTIATION; METABOLISM; PATHOLOGY; TIME; TUMOR CELL CULTURE;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; APOPTOSIS; APOPTOSIS INDUCING FACTOR; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; BREAST NEOPLASMS; CASPASE 9; CELL PROLIFERATION; CYCLIN D1; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; MICE; MICE, INBRED BALB C; NITRILES; PHENOLS; PYRAZOLES; RECEPTORS, PROGESTERONE; TIME FACTORS; TUMOR BURDEN; TUMOR CELLS, CULTURED;

EID: 79952117071     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0659-8     Document Type: Article

References (61)

1. Jordan VC, Brodie AM (2007) Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer. Steroids 72:7-25 (Pubitemid 46037765)
2. Lacroix M, LeClercq G (2004) Relevance of breast cancer cell lines as models for breast tumours: An update. Breast Cancer Res Treat 83:249-289 (Pubitemid 38264873)
3. Shafie SM, Grantham FH (1981) Role of hormones in the growth and regression of human breast cancer cells (MCF-7) transplanted into athymic nude mice. J Natl Cancer Inst 67:51-56 (Pubitemid 11087550)
4. Russo IH, Russo J (1998) Role of hormones in mammary cancer initiation and progression. J Mammary Gland Biol Neoplasia 3:49-61 (Pubitemid 128513219)
5. Fernandez SV, Russo IH, Russo J (2006) Estradiol and its metabolites 4-hydroxyestradiol and 2-hydroxyestradiol induce mutations in human breast epithelial cells. Int J Cancer 118:1862-1868
6. Lewis JS, Meeke K, Osipo C, Ross EA, Kidawi N, Li T, Bell E, Chandel NS, Jordan VC (2005) Intrinsic mechanism of estradiolinduced apoptosis in breast cancer cells resistant to estrogen deprivation. J Natl Cancer Inst 97:1746-1759 (Pubitemid 41782284)
7. Carter AC, Sedransk N, Kelley RM, Ansfield FJ, Ravdin RG, Talley RW, Potter NR (1977) Diethylstilbestrol: recommended dosages for different categories of breast cancer patients. Report of the Cooperative Breast Cancer Group. JAMA 237:8-2079
8. Jeng MH, Jiang SY, Jordan VC (1994) Paradoxical regulation of estrogen-dependent growth factor gene expression in estrogen receptor (ER)-negative human breast cancer cells stably expressing ER. Cancer Lett 82:123-128 (Pubitemid 24231975)
9. Kushner PJ, Hort E, Shine J, Baxter JD, Greene GL (1990) Construction of cell lines that express high levels of the human estrogen receptor and are killed by estrogens. Mol Endocrinol 4:1465-1473 (Pubitemid 20356607)
10. Sotoca AM, van den Berg H, Vervoort J, van der Saag P, Strom A, Gustafsson JA, Rietjens I, Murk AJ (2008) Influence of cellular ERalpha/ERbeta ratio on the ERalpha-Agonist induced proliferation of human T47D breast cancer cells. Toxicol Sci 105:303-311
11. Brunner N, Spang-Thomsen M, Cullen K (1996) The T61 human breast cancer xenograft: An experimental model of estrogen therapy of breast cancer. Breast Cancer Res Treat 39:87-92 (Pubitemid 26136506)
12. Kordon E, Lanari C, Molinolo AA, Elizalde PV, Charreau EH, Pasqualini CD (1991) Estrogen inhibition of MPA-induced mouse mammary tumor transplants. Int J Cancer 49:900-905
13. Jordan VC (2008) The 38th David A. Karnofsky lecture: the paradoxical actions of estrogen in breast cancer-survival or death? J Clin Oncol 26:3073-3082
14. Song RX, Santen RJ (2003) Apoptotic action of estrogen. Apoptosis 8:55-60 (Pubitemid 36133138)
15. Vanzulli S, Efeyan A, Benavides F, Helguero L, Peters G, Shen J, Conti CJ, Lanari C, Molinolo A (2002) p21, p27 and p53 in estrogen and antiprogestin-induced tumor regression of experimental mouse mammary ductal carcinomas. Carcinogenesis 23:749-757 (Pubitemid 34567513)
16. Zhang Y, Zhao H, Asztalos S, Chisamore M, Sitabkhan Y, Tonetti DA (2009) Estradiol-induced regression in T47D:A18/PKCalpha tumors requires the estrogen receptor and interaction with the extracellular matrix. Mol Cancer Res 7:498-510
17. Song RX, Zhang Z, Mor G, Santen RJ (2005) Down-regulation of Bcl-2 enhances estrogen apoptotic action in long-Term estradioldepleted ER(?) breast cancer cells. Apoptosis 10:667-678 (Pubitemid 40896672)
18. Green D, Kroemer G (1998) The central executioners of apoptosis: caspases or mitochondria Trends Cell Biol 8:267-271 (Pubitemid 28310224)
19. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM, Kroemer G (1999) Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397:441-446
20. Ye H, Cande C, Stephanou NC, Jiang S, Gurbuxani S, Larochette N, Daugas E, Garrido C, Kroemer G, Wu H (2002) DNA binding is required for the apoptogenic action of apoptosis inducing factor. Nat Struct Biol 9:680-684 (Pubitemid 34977301)
21. Chao DT, Korsmeyer SJ (1998) BCL-2 family: regulators of cell death. Annu Rev Immunol 16:395-419 (Pubitemid 28183370)
22. Celis JE, Madsen P, Celis A, Nielsen HV, Gesser B (1987) Cyclin (PCNA, auxiliary protein of DNA polymerase delta) is a central component of the pathway(s) leading to DNA replication and cell division. FEBS Lett 220:1-7
23. Eeckhoute J, Carroll JS, Geistlinger TR, Torres-Arzayus MI, Brown M (2006) A cell-Type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer. Genes Dev 20:2513-2526 (Pubitemid 44396837)
24. Boonyaratanakornkit V, Bi Y, Rudd M, Edwards DP (2008) The role and mechanism of progesterone receptor activation of extranuclear signaling pathways in regulating gene transcription and cell cycle progression. Steroids 73:922-928
25. Leger JG, Montpetit ML, Tenniswood MP (1987) Characterization and cloning of androgen-repressed mRNAs from rat ventral prostate. Biochem Biophys Res Commun 147:196-203
26. Guenette RS, Corbeil HB, Leger J, Wong K, Mezl V, Mooibroek M, Tenniswood M (1994) Induction of gene expression during involution of the lactating mammary gland of the rat. J Mol Endocrinol 12:47-60 (Pubitemid 24065274)
27. Zierau O, O'Sullivan J, Morrissey C, McDonald D, Wunsche W, Schneider MR, Tenniswood MP, Vollmer G (2004) Tamoxifen exerts agonistic effects on clusterin and complement C3 gene expression in RUCA-I primary xenografts and metastases but not normal uterus. Endocr Relat Cancer 11:823-830 (Pubitemid 40065554)
28. Zhang H, Kim JK, Edwards CA, Xu Z, Taichman R, Wang CY (2005) Clusterin inhibits apoptosis by interacting with activated Bax. Nat Cell Biol 7:909-915 (Pubitemid 41486292)
29. Moore MR, Conover JL, Franks KM (2000) Progestin effects on long-Term growth, death, and Bcl-xL in breast cancer cells. Biochem Biophys Res Commun 277:650-654
30. Dong L, Wang W, Wang F, Stoner M, Reed JC, Harigai M, Samudio I, Kladde MP, Vyhlidal C, Safe S (1999) Mechanisms of transcriptional activation of bcl-2 gene expression by 17betaestradiol in breast cancer cells. J Biol Chem 274:32099-32107
31. Helguero LA, Faulds MH, Gustafsson JA, Haldosen LA (2005) Estrogen receptors alfa (ERalpha) and beta (ERbeta) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11. Oncogene 24:6605-6616 (Pubitemid 41486791)
32. Roger P, Sahla ME, Makela S, Gustafsson JA, Baldet P, Rochefort H (2001) Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res 61:2537-2541 (Pubitemid 32685835)
33. Zeng Q, Chen G, Vlantis A, Tse G, van Hasselt C (2008) The contributions of oestrogen receptor isoforms to the development of papillary and anaplastic thyroid carcinomas. J Pathol 214:425-433 (Pubitemid 351350536)
34. Harrington WR, Kim SH, Funk CC, Madak-Erdogan Z, Schiff R, Katzenellenbogen JA, Katzenellenbogen BS (2006) Estrogen dendrimer conjugates that preferentially activate extranuclear, nongenomic versus genomic pathways of estrogen action. Mol Endocrinol 20:491-502 (Pubitemid 43291204)
35. Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, Katzenellenbogen JA (2001) Estrogen receptor-beta potencyselective ligands: structure-Activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem 44:4230-4251 (Pubitemid 33095330)
36. Lanari C, Lamb CA, Fabris VT, Helguero LA, Soldati R, Bottino MC, Giulianelli S, Cerliani JP, Wargon V, Molinolo A (2009) The MPA mouse breast cancer model: evidence for a role of progesterone receptors in breast cancer. Endocr Relat Cancer 16:333-350
37. Montecchia MF, Lamb C, Molinolo AA, Luthy IA, Pazos P, Charreau E, Vanzulli S, Lanari C (1999) Progesterone receptor involvement in independent tumor growth in MPA-induced murine mammary adenocarcinomas. J Steroid Biochem Mol Biol 68:11-21 (Pubitemid 29130381)
38. Lamb CA, Helguero LA, Fabris V, Lucas C, Molinolo AA, Lanari C (2003) Differential effects of raloxifene, tamoxifen and fulvestrant on a murine mammary carcinoma. Breast Cancer Res Treat 79:25-35 (Pubitemid 36561040)
39. Lanari C, Luthy I, Lamb CA, Fabris V, Pagano E, Helguero LA, Sanjuan N, Merani S, Molinolo AA (2001) Five novel hormoneresponsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins. Cancer Res 61:293-302 (Pubitemid 32095730)
40. Aliaga A, Rousseau JA, Ouellette R, Cadorette J, van Lier JE, Lecomte R, Benard F (2004) Breast cancer models to study the expression of estrogen receptors with small animal PET imaging. Nucl Med Biol 31:761-770 (Pubitemid 38887758)
41. Institute of Laboratory Animal Resources CoLSNRC (1996) Guide for the care and use of laboratory animals. National Academy Press, Washington, DC 42. Wargon V, Helguero LA, Bolado J, Rojas P, Novaro V, Molinolo A, Lanari C (2009) Reversal of antiprogestin resistance and progesterone receptor isoform ratio in acquired resistant mammary carcinomas. Breast Cancer Res Treat 116:449-460
42. Lamb CA, Helguero LA, Giulianelli S, Soldati R, Vanzulli SI, Molinolo A, Lanari C (2005) Antisense oligonucleotides targeting the progesterone receptor inhibit hormone-independent breast cancer growth in mice. Breast Cancer Res 7:R1111-R1121
43. Soule HD, Vazguez J, Long A, Albert S, Brennan M (1973) A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51:1409-1416
44. Dran G, Luthy IA, Molinolo AA, Charreau EH, Pasqualini CD, Lanari C (1995) Effect of medroxyprogesterone acetate (MPA) and serum factors on cell proliferation in primary cultures of an MPA-induced mammary adenocarcinoma. Breast Cancer Res Treat 35:173-186
45. Giulianelli S, Cerliani JP, Lamb CA, Fabris VT, Bottino MC, Gorostiaga MA, Novaro V, Gongora A, Baldi A, Molinolo A, Lanari C (2008) Carcinoma-Associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: A role for the FGF-2/FGFR-2 axis. Int J Cancer 123:2518-2531
46. Helguero LA, Viegas M, Asaithamby A, Shyamala G, Lanari C, Molinolo AA (2003) Progesterone receptor expression in medroxyprogesterone acetate-induced murine mammary carcinomas and response to endocrine treatment. Breast Cancer Res Treat 79:379-390 (Pubitemid 36750945)
47. Murphy LC, Peng B, Lewis A, Davie JR, Leygue E, Kemp A, Ung K, Vendetti M, Shiu R (2005) Inducible upregulation of oestrogen receptor-beta1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells. J Mol Endocrinol 34:553-566 (Pubitemid 40585201)
48. Vanzulli SI, Soldati R, Meiss R, Colombo L, Molinolo AA, Lanari C (2005) Estrogen or antiprogestin treatment induces complete regression of pulmonary and axillary metastases in an experimental model of breast cancer progression. Carcinogenesis 26:1055-1063 (Pubitemid 41214298)
49. Andjilani M, Droz JP, Benahmed M, Tabone E (2005) Alpha6 integrin subunit mediates laminin enhancement of cisplatininduced apoptosis in testicular tumor germ cells. Int J Cancer 117:68-81 (Pubitemid 41262761)
50. Wickramasinghe NS, Manavalan TT, Dougherty SM, Riggs KA, Li Y, Klinge CM (2009) Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells. Nucleic Acids Res 37:2584-2595
51. Sempere LF, Christensen M, Silahtaroglu A, Bak M, Heath CV, Schwartz G, Wells W, Kauppinen S, Cole CN (2007) Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res 67:11612-11620
52. Harris HA, Katzenellenbogen JA, Katzenellenbogen BS (2002) Characterization of the biological roles of the estrogen receptors, ERalpha and ERbeta, in estrogen target tissues in vivo through the use of an ERalpha-selective ligand. Endocrinology 143:4172-4177 (Pubitemid 35239546)
53. Frasor J, Barnett DH, Danes JM, Hess R, Parlow AF, Katzenellenbogen BS (2003) Response-specific and ligand dose-dependent modulation of estrogen receptor (ER) alpha activity by ERbeta in the uterus. Endocrinology 144:3159-3166 (Pubitemid 36819918)
54. Sanchez-Criado JE, Martin De Las MJ, Bellido C, Tena-Sempere M, Aguilar R, Blanco A (2004) Biological role of pituitary estrogen receptors ERalpha and ERbeta on progesterone receptor expression and action and on gonadotropin and prolactin secretion in the rat. Neuroendocrinology 79:247-258 (Pubitemid 38969870)
55. Walf AA, Rhodes ME, Frye CA (2004) Antidepressant effects of ERbeta-selective estrogen receptor modulators in the forced swim test. Pharmacol Biochem Behav 78:523-529 (Pubitemid 38901019)
56. Fritzemeier KH, Hillisch A, Elger W, Kaufmann U, Kollenkirchen U, Kosemund D, Lindenthal B, Muller G, Muhn P, Nubbemeyer R, Peters O, Siebel P, Hegele-Hartung C (2004) Biological effects of ERalpha-And ERbeta-selective estrogens. Ernst Scher Res Found Workshop 46:127-150
57. Simian M, Molinolo A, Lanari C (2006) Involvement of matrix metalloproteinase activity in hormone-induced mammary tumor regression. Am J Pathol 168:270-279 (Pubitemid 43062579)
58. Schuler M, Green DR (2001) Mechanisms of p53-dependent apoptosis. Biochem Soc Trans 29:684-688 (Pubitemid 33131760)
59. Johnstone RW, Ruefli AA, Lowe SW (2002) Apoptosis: A link between cancer genetics and chemotherapy. Cell 108:153-164 (Pubitemid 34161136)
60. Giulianelli S, Novaro V, Lanari C (2009) Nuclear estrogen receptors alpha are involved in progestin-dependent and independent mammary tumor growth. In: Proceedings of the 100th annual meeting of the American association for cancer research; 2009 Apr 18-22; Denver, CO. Philadelphia (PA): AACR; 2009. Abstract 3858
61. Ariazi EA, Ariazi JL, Cordera F, Jordan VC (2006) Estrogen receptors as therapeutic targets in breast cancer. Curr Top Med Chem 6:181-202